Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2CNS 2Other hematologic neoplasm 1Head & Neck 1

Conditions

Brain Neoplasms 2

Interventions

Temozolomide 623Radiotherapy 411Bevacizumab 257Magnetic Resonance Spectroscopy 227Cyclophosphamide 179Radiosurgery 163Carboplatin 160Etoposide 132Radiation 129Vincristine 115Irinotecan 115Cisplatin 103Filgrastim 100Specimen Handling 90Nivolumab 88pembrolizumab 84Surgical Procedures, Operative 83Lomustine 83Topotecan 73Doxorubicin 61Melphalan 59Carmustine 57Radiotherapy, Intensity-Modulated 56sargramostim 53Isotretinoin 53Peripheral Blood Stem Cell Transplantation 52Granulocyte Colony-Stimulating Factor 51Chemotherapy, Adjuvant 51Blood Specimen Collection 51Erlotinib Hydrochloride 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neurofeedback × CNS × Clear all
NCT07085494 2026-01-27

Neurofeedback and Cognitive Training for PBTS

The University of Hong Kong

Phase NA Enrolling by invitation
50 enrolled
CNS

Brain Neoplasms

NCT00961922 2012-10-04

PRISMA

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Unknown
105 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡